BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 12207636)

  • 21. Differential effectiveness of newer and older antidepressants appears mediated by an age effect on the phenotypic expression of depression.
    Parker G
    Acta Psychiatr Scand; 2002 Sep; 106(3):168-70. PubMed ID: 12197852
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of antidepressants and risk of colorectal cancer: a nested case-control study.
    Xu W; Tamim H; Shapiro S; Stang MR; Collet JP
    Lancet Oncol; 2006 Apr; 7(4):301-8. PubMed ID: 16574545
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antidepressants, autonomic function and mortality in patients with coronary heart disease: data from the Heart and Soul Study.
    Zimmermann-Viehoff F; Kuehl LK; Danker-Hopfe H; Whooley MA; Otte C
    Psychol Med; 2014 Oct; 44(14):2975-84. PubMed ID: 25065442
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective serotonin reuptake inhibiting antidepressants are associated with an increased risk of nonvertebral fractures.
    Ziere G; Dieleman JP; van der Cammen TJ; Hofman A; Pols HA; Stricker BH
    J Clin Psychopharmacol; 2008 Aug; 28(4):411-7. PubMed ID: 18626268
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SSRI-induced reversal of levodopa benefit in two patients with dopa-responsive dystonia.
    Mathen D; Marsden CD; Bhatia KP
    Mov Disord; 1999 Sep; 14(5):874-6. PubMed ID: 10495057
    [No Abstract]   [Full Text] [Related]  

  • 26. Co-prescribing of SSRIs and TCAs in Australia: how often does it occur and who is doing it?
    McManus P; Mant A; Mitchell P; Birkett D; Dudley J
    Br J Clin Pharmacol; 2001 Jan; 51(1):93-8. PubMed ID: 11167670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of Functional Abdominal Pain With Antidepressants: Benefits, Adverse Effects, and the Gastroenterologist's Role.
    Zar-Kessler CAM; Belkind-Gerson J; Bender S; Kuo BM
    J Pediatr Gastroenterol Nutr; 2017 Jul; 65(1):16-21. PubMed ID: 28644344
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Parkinson's disease].
    Terada S; Kuroda S; Ishizu H
    Ryoikibetsu Shokogun Shirizu; 2003; (40):257-60. PubMed ID: 14626114
    [No Abstract]   [Full Text] [Related]  

  • 29. Selective serotonin reuptake inhibitors have broadened the utilisation of antidepressant treatment in accordance with recommendations. Findings from a Swedish prescription database.
    Isacsson G; Boëthius G; Henriksson S; Jones JK; Bergman U
    J Affect Disord; 1999 Apr; 53(1):15-22. PubMed ID: 10363662
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SSRI-TCA combination in the treatment of resistant depression.
    Terao T; Ikemura N
    J Clin Psychiatry; 2000 Jul; 61(7):529. PubMed ID: 10937615
    [No Abstract]   [Full Text] [Related]  

  • 31. Retrospective study of selegiline-antidepressant drug interactions and a review of the literature.
    Ritter JL; Alexander B
    Ann Clin Psychiatry; 1997 Mar; 9(1):7-13. PubMed ID: 9167831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gender differences in response to differing antidepressant drug classes: two negative studies.
    Parker G; Parker K; Austin MP; Mitchell P; Brotchie H
    Psychol Med; 2003 Nov; 33(8):1473-7. PubMed ID: 14672256
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Indications for and outcome of antidepressant medication in a general population: a prescription database and medical record study, in Jämtland county, Sweden, 1995.
    Henriksson S; Boëthius G; Håkansson J; Isacsson G
    Acta Psychiatr Scand; 2003 Dec; 108(6):427-31. PubMed ID: 14616223
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety of selegiline (deprenyl) in the treatment of Parkinson's disease.
    Heinonen EH; Myllylä V
    Drug Saf; 1998 Jul; 19(1):11-22. PubMed ID: 9673855
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serotonin-norepinephrine reuptake inhibitor and selective serotonin reuptake inhibitor use and risk of fractures: a new-user cohort study among US adults aged 50 years and older.
    Lanteigne A; Sheu YH; Stürmer T; Pate V; Azrael D; Swanson SA; Miller M
    CNS Drugs; 2015 Mar; 29(3):245-52. PubMed ID: 25708711
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Selective serotonin reuptake inhibitors and newer antidepressive substances in child and adolescent psychiatry].
    Heiser P; Remschmidt H
    Z Kinder Jugendpsychiatr Psychother; 2002 Aug; 30(3):173-83. PubMed ID: 12227220
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of Antidepressant Medication Type With the Incidence of Cardiovascular Disease in the ARIC Study.
    Almuwaqqat Z; Jokhadar M; Norby FL; Lutsey PL; O'Neal WT; Seyerle A; Soliman EZ; Chen LY; Bremner JD; Vaccarino V; Shah AJ; Alonso A
    J Am Heart Assoc; 2019 Jun; 8(11):e012503. PubMed ID: 31140335
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Course of antidepressant treatment with tricyclic versus selective serotonin reuptake inhibitor agents: a comparison in managed care and fee-for-service environments.
    Fairman KA; Teitelbaum F; Drevets WC; Engquist G; Kreisman JJ; Norusis MJ
    Am J Manag Care; 1997 Mar; 3(3):453-65. PubMed ID: 10169521
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: a meta-analysis.
    Anderson IM; Tomenson BM
    BMJ; 1995 Jun; 310(6992):1433-8. PubMed ID: 7613276
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of levodopa on reduced nerve growth factor levels in patients with Parkinson disease.
    Müller T; Lang UE; Muhlack S; Welnic J; Hellweg R
    Clin Neuropharmacol; 2005; 28(5):238-40. PubMed ID: 16239764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.